Literature DB >> 23598475

Projections of costs, financing, and additional resource requirements for low- and lower middle-income country immunization programs over the decade, 2011-2020.

Gian Gandhi1, Patrick Lydon, Santiago Cornejo, Logan Brenzel, Sandra Wrobel, Hugh Chang.   

Abstract

The Decade of Vaccines Global Vaccine Action Plan has outlined a set of ambitious goals to broaden the impact and reach of immunization across the globe. A projections exercise has been undertaken to assess the costs, financing availability, and additional resource requirements to achieve these goals through the delivery of vaccines against 19 diseases across 94 low- and middle-income countries for the period 2011-2020. The exercise draws upon data from existing published and unpublished global forecasts, country immunization plans, and costing studies. A combination of an ingredients-based approach and use of approximations based on past spending has been used to generate vaccine and non-vaccine delivery costs for routine programs, as well as supplementary immunization activities (SIAs). Financing projections focused primarily on support from governments and the GAVI Alliance. Cost and financing projections are presented in constant 2010 US dollars (US$). Cumulative total costs for the decade are projected to be US$57.5 billion, with 85% for routine programs and the remaining 15% for SIAs. Delivery costs account for 54% of total cumulative costs, and vaccine costs make up the remainder. A conservative estimate of total financing for immunization programs is projected to be $34.3 billion over the decade, with country governments financing 65%. These projections imply a cumulative funding gap of $23.2 billion. About 57% of the total resources required to close the funding gap are needed just to maintain existing programs and scale up other currently available vaccines (i.e., before adding in the additional costs of vaccines still in development). Efforts to mobilize additional resources, manage program costs, and establish mutual accountability between countries and development partners will all be necessary to ensure the goals of the Decade of Vaccines are achieved. Establishing or building on existing mechanisms to more comprehensively track resources and commitments for immunization will help facilitate these efforts.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2013        PMID: 23598475     DOI: 10.1016/j.vaccine.2013.01.036

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

1.  Charting the evolution of approaches employed by the Global Alliance for Vaccines and Immunizations (GAVI) to address inequities in access to immunization: a systematic qualitative review of GAVI policies, strategies and resource allocation mechanisms through an equity lens (1999-2014).

Authors:  Gian Gandhi
Journal:  BMC Public Health       Date:  2015-11-30       Impact factor: 3.295

Review 2.  Valuing vaccination.

Authors:  Till Bärnighausen; David E Bloom; Elizabeth T Cafiero-Fonseca; Jennifer Carroll O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-18       Impact factor: 11.205

3.  Overview of global, regional, and national routine vaccination coverage trends and growth patterns from 1980 to 2009: implications for vaccine-preventable disease eradication and elimination initiatives.

Authors:  Aaron S Wallace; Tove K Ryman; Vance Dietz
Journal:  J Infect Dis       Date:  2014-11-01       Impact factor: 5.226

4.  Towards the development of an oral vaccine against porcine cysticercosis: expression of the protective HP6/TSOL18 antigen in transgenic carrots cells.

Authors:  Elizabeth Monreal-Escalante; Dania O Govea-Alonso; Marisela Hernández; Jacquelynne Cervantes; Jorge A Salazar-González; Andrea Romero-Maldonado; Gabriela Rosas; Teresa Garate; Gladis Fragoso; Edda Sciutto; Sergio Rosales-Mendoza
Journal:  Planta       Date:  2015-11-27       Impact factor: 4.116

Review 5.  Pertussis: Microbiology, Disease, Treatment, and Prevention.

Authors:  Paul E Kilgore; Abdulbaset M Salim; Marcus J Zervos; Heinz-Josef Schmitt
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

6.  Vaccination and all-cause child mortality from 1985 to 2011: global evidence from the Demographic and Health Surveys.

Authors:  Mark E McGovern; David Canning
Journal:  Am J Epidemiol       Date:  2015-10-08       Impact factor: 4.897

7.  Health system cost of delivering routine vaccination in low- and lower-middle income countries: what is needed over the next decade?

Authors:  Patrick Lydon; Gian Gandhi; Jos Vandelaer; Jean-Marie Okwo-Bele
Journal:  Bull World Health Organ       Date:  2014-02-07       Impact factor: 9.408

8.  Microneedle-mediated immunization of an adenovirus-based malaria vaccine enhances antigen-specific antibody immunity and reduces anti-vector responses compared to the intradermal route.

Authors:  John B Carey; Anto Vrdoljak; Conor O'Mahony; Adrian V S Hill; Simon J Draper; Anne C Moore
Journal:  Sci Rep       Date:  2014-08-21       Impact factor: 4.379

9.  Funding gap for immunization across 94 low- and middle-income countries.

Authors:  Sachiko Ozawa; Simrun Grewal; Allison Portnoy; Anushua Sinha; Richard Arilotta; Meghan L Stack; Logan Brenzel
Journal:  Vaccine       Date:  2016-10-28       Impact factor: 3.641

10.  Monitoring what governments "give for" and "spend on" vaccine procurement: Vaccine Procurement Assistance and Vaccine Procurement Baseline.

Authors:  E A S Nelson; David E Bloom; Richard T Mahoney
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.